Financials
- Market Capitalization 271.99 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.82
市销率
43.33
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3410 | MGNX MacroGenics, Inc. - Common Stock | 4.32 USD | +0.70% | -6.70% | +4.10% | +188.00% | 274.59 M USD | ||
| 3414 | ALXO ALX Oncology Holdings Inc. - Common Stock | 2.03 USD | +1.50% | -12.88% | +27.67% | +331.91% | 273.16 M USD | ||
| 3461 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 8.68 USD | +0.70% | -14.65% | +0.70% | -5.24% | 255.03 M USD | ||
| 3469 | SRZN Surrozen, Inc. - Common Stock | 21.79 USD | -0.41% | -5.92% | -6.04% | +161.90% | 252.99 M USD |